Company history
| 2023.11 | Joint research on Pancreatic cancer, cholangiocarcinoma diagnostic kit (Korea University Hospital) |
| 2023.10 | Joint research on Breast cancer diagnostic kit (Seoul National University Hospital, the Catholic University of Medicine Seoul St. Mary’s Hospital) |
| 2022.10 | Joint research on Pancreatic cancer diagnosis (Asan Medical Center’s Hepatobiliary and Pancreatic Surgery) |
| 2022.06 | Series B investment (6.5 million) |
| 2021.11 | Started joint development of pancreatic cancer and biliary tract cancer diagnosis kit (Korea University Hospital) |
| 2021.10 | Joint development of advanced genetic diagnostic kit (Seoul St. Mary's Hospital) |
| Commencement of joint development of breast cancer diagnosis kit (Seoul National University Hospital) |
|
| 2021.09 | Korea University P-HIS Project Group (Huniverse Global) MOU (Joint use of genomic and clinical data) |
| 2021.06 | Selected as a start-up leap forward package support project |
| 2021.04 | Selected for scale-up technology commercialization task (1.06 billion) |
| Selected for the development of liquid biopsy technology for pan-ministerial medical devices (1.1 billion won) | |
| 2021.03 | Established GMP manufacturing facility |
| 2020.06 | Lung cancer diagnosis joint research (Korea University Thoracic Surgery) |
| 2020.03 | Patent registration (10-2086689) |
| 2019.09 | Investment in subsidies (500 million won) |
| 2019.06 | Series A investment (2 billion won) |
| 2019.06 | TIPS program start-up commercialization / Overseas Marketing Selection (Ministry of SMEs and Startups) |
| 2019.06 | Selected as TIPS technology startup team (Small and Medium Business Technology Information Promotion Agency) |
| 2019.02 | Certificate Venture Company |
| 2018.09 | Patent support project (Health Business Promotion Agency) |
| 2018.09 | Startup success package project (Small and Medium Business Corporation) |
| 2018.08 | Moved into Seoul Bio Hub |
| 2017.11 | Established GeneCker Co., Ltd. |